Functionally, blockade of the CAF-associated CXCL12–CXCR4 pathway inhibited tumor-cell migration, invasion, and angiogenesis, accompanied by slower orthotopic tumor growth and reduced metastasis. Here, CXCL12 is linked to neoplasm.